CD44 and colorectal carcinoma: Moreover, data showed that, the weakened proliferative potential and self‐renewal ability, and the decreased proportion of CD44+ and CD133+ CRC cells mediated by down‐regulation of DCLK1, could be rescued by DCLK1 exogenous expression (Figure S3).